Search Results - "Ferguson, G T"

Adherence to inhaled therapy, mortality and hospital admission in COPD by Vestbo, J, Anderson, J A, Calverley, P M A, Celli, B, Ferguson, G T, Jenkins, C, Knobil, K, Willits, L R, Yates, J C, Jones, P W

“…Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. Data on drug…”
Get more information

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results by Crim, C, Calverley, P. M. A, Anderson, J. A, Celli, B, Ferguson, G. T, Jenkins, C, Jones, P. W, Willits, L. R, Yates, J. C, Vestbo, J

“…Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated with chronic obstructive pulmonary disease (COPD). However, little is…”
Get full text

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study by JENKINS, C. R, CELL, B, ANDERSON, J. A, FERGUSON, G. T, JONES, P. W, VESTBO, J, YATES, J. C, CALVERLE, P. M. A

“…We investigated the impact of season relative to other determinants of chronic obstructive pulmonary disease (COPD) exacerbation frequency in a long-term…”
Get full text

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program by Ferguson, G T, Enright, P L, Buist, A S, Higgins, M W

“…COPD is easily detected in its preclinical phase using spirometry, and successful smoking cessation (a cost-effective intervention) prevents further disease…”
Get more information

Methods for therapeutic trials in COPD: lessons from the TORCH trial by Keene, O. N, Vestbo, J, Anderson, J. A, Calverley, P. M. A, Celli, B, Ferguson, G. T, Jenkins, C, Jones, P. W

“…The TORCH (Towards a Revolution in COPD Health) trial has highlighted some important issues in the design and analysis of long term trials in chronic…”
Get full text

Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data by Anderson, Martin, Collison, Kathryn, Drummond, M Bradley, Hamilton, Melanie, Jain, Renu, Martin, Neil, Mularski, Richard A, Thomas, Mike, Zhu, Chang-Qing, Ferguson, Gary T

“…The influence of peak inspiratory flow (PIF) on dose delivery from dry powder inhalers (DPIs) and association with treatment efficacy in patients with chronic…”
Get full text

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD by Dorinsky, P M, Reisner, C, Ferguson, G T, Menjoge, S S, Serby, C W, Witek, Jr, T J

“…To determine whether the combination of ipratropium bromide and albuterol results in greater and more consistent pulmonary function test (PFT) response rates…”
Get more information

Sugar cane (Saccharum officinarum L) burning and asthma in southeast Louisiana, USA by BOOPATHY, R, ASRABADI, B. R, FERGUSON, T. G

Get full text

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy by Ferguson, Gary T, Kerwin, Edward M, Rheault, Tara, Bengtsson, Thomas, Rickard, Kathleen

“…Ensifentrine is an inhaled dual inhibitor of phosphodiesterase (PDE) 3 and 4 that has shown bronchodilatory effects and symptom improvement in clinical studies…”
Get full text

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS by Martinez, Fernando J, Ferguson, Gary T, Bourne, Eric, Ballal, Shaila, Darken, Patrick, Aurivillius, Magnus, Dorinsky, Paul, Reisner, Colin

“…In the Phase III, 24-week KRONOS study (NCT02497001), triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) reduced…”
Get full text

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD by Sethi, Sanjay, Kerwin, Edward, Watz, Henrik, Ferguson, Gary T, Mroz, Robert M, Segarra, Rosa, Molins, Eduard, Jarreta, Diana, Garcia Gil, Esther

“…AMPLIFY assessed the efficacy and safety of aclidinium bromide/formoterol fumarate (AB/FF) vs its monocomponents and tiotropium (TIO) in patients with…”
Get full text

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease by Ohar, Jill A, Ferguson, Gary T, Mahler, Donald A, Drummond, M Bradley, Dhand, Rajiv, Pleasants, Roy A, Anzueto, Antonio, Halpin, David M G, Price, David B, Drescher, Gail S, Hoy, Haley M, Haughney, John, Hess, Michael W, Usmani, Omar S

“…Dry powder inhalers (DPIs) are breath actuated, and patients using DPIs need to generate an optimal inspiratory flow during the inhalation maneuver for…”
Get full text

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow by Mahler, Donald A, Ludwig-Sengpiel, Andrea, Ferguson, Gary T, de la Hoz, Alberto, Ritz, John, Shaikh, Asif, Watz, Henrik

“…Inhaled bronchodilator therapy is currently the mainstay of treatment for patients with chronic obstructive pulmonary disease (COPD). Some inhalers require…”
Get full text

Use of twitch pressures to assess diaphragmatic function and central drive by Ferguson, G T

“…Transdiaphragmatic pressures generated by phrenic nerve twitches have been proposed as a means to assess diaphragmatic function and central drive, but their…”
Get more information

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD by Ichinose, Masakazu, Fukushima, Yasushi, Inoue, Yoshikazu, Hataji, Osamu, Ferguson, Gary T, Rabe, Klaus F, Hayashi, Nobuya, Okada, Hiroshi, Takikawa, Mami, Bourne, Eric, Ballal, Shaila, DeAngelis, Kiernan, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul

“…Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) is a triple fixed-dose combination for COPD. The long-term safety of triple…”
Get full text

Update on pharmacologic therapy for chronic obstructive pulmonary disease by Ferguson, G T

“…As described throughout this article, significant improvements continue to occur in the pharmacologic management of COPD. These improvements range from…”
Get more information

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study by Ichinose, Masakazu, Fukushima, Yasushi, Inoue, Yoshikazu, Hataji, Osamu, Ferguson, Gary T, Rabe, Klaus F, Hayashi, Nobuya, Okada, Hiroshi, Takikawa, Mami, Bourne, Eric, Ballal, Shaila, DeAngelis, Kiernan, Aurivillius, Magnus, Dorinsky, Paul, Reisner, Colin

“…KRONOS, a Phase III, multicenter, randomized, double-blind study (NCT02497001) conducted in Canada, China, Japan, and the USA, assessed the efficacy and safety…”
Get full text

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline by Ferguson, Gary T, Shaikh, Asif, Tetzlaff, Kay, Mueller, Achim, Magnussen, Helgo, Watz, Henrik

“…Purpose: In the Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management (WISDOM) trial, inhaled corticosteroid (ICS) withdrawal in patients…”
Get full text

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study by Ferguson, Gary T, Skärby, Tor, Nordenmark, Lars H, Lamarca, Rosa, Aksomaityte, Audrone, Lythgoe, Dan, Gilbert, Ileen, Trudo, Frank

“…Moderate and severe COPD exacerbations are a significant health-care burden, but patients also experience "mild" exacerbations, or COPD symptom-related…”
Get full text

Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD by Ferguson, Gary T, Rodriguez-Roisin, Roberto, Reisner, Colin, Maes, Andrea, Siddiqui, Shahid, Martin, Ubaldo J

“…The efficacy and tolerability of GFF MDI (Bevespi Aerosphere ), a fixed-dose combination of glycopyrronium (GP)/formoterol fumarate dihydrate (FF) 14.4/10 μg…”
Get full text